EPRX
Price:
$5.97
Market Cap:
$214.15M
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company's product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its n...[Read more]
Industry
Biotechnology
IPO Date
2024-04-05
Stock Exchange
NASDAQ
Ticker
EPRX
According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -53.61%. This represents a change of 183.72% compared to the average of -18.90% of the last 4 quarters.
The mean historical ROE of Eupraxia Pharmaceuticals Inc. over the last ten years is -175.65%. The current -53.61% ROE has changed -69.48% with respect to the historical average. Over the past ten years (40 quarters), EPRX's ROE was at its highest in in the March 2020 quarter at 11.84%. The ROE was at its lowest in in the December 2023 quarter at -460.36%.
Average
-175.65%
Median
-72.22%
Minimum
-1273.38%
Maximum
119.65%
Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 603.79%
Maximum Annual ROE = 119.65%
Minimum Annual Increase = -698.36%
Minimum Annual ROE = -1273.38%
| Year | ROE | Change |
|---|---|---|
| 2025 | -47.93% | -34.05% |
| 2024 | -72.68% | -94.29% |
| 2023 | -1273.38% | 603.79% |
| 2022 | -180.93% | 60.45% |
| 2021 | -112.77% | -698.36% |
| 2020 | 18.85% | -53.54% |
| 2019 | 40.57% | -66.10% |
| 2018 | 119.65% | -265.66% |
The current ROE of Eupraxia Pharmaceuticals Inc. (EPRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-464.66%
5-year avg
-337.54%
10-year avg
-175.65%
Eupraxia Pharmaceuticals Inc.’s ROE is greater than MediWound Ltd. (-67.22%), greater than Nautilus Biotechnolgy, Inc. (-37.58%), less than Neonc Technologies Holdings, Inc. (284.28%), greater than Orchestra BioMed Holdings, Inc. (-137.99%), greater than Aardvark Therapeutics, Inc. Common Stock (-61.71%), greater than SELLAS Life Sciences Group, Inc. (-47.12%), less than Inventiva S.A. (1.87%), less than Cartesian Therapeutics, Inc. (194.13%), greater than Genfit S.A. (-596.44%), greater than Protara Therapeutics, Inc. (-38.70%),
| Company | ROE | Market cap |
|---|---|---|
| -67.22% | $184.34M | |
| -37.58% | $132.16M | |
| 284.28% | $90.76M | |
| -137.99% | $227.55M | |
| -61.71% | $116.42M | |
| -47.12% | $1.88B | |
| 1.87% | $234.44M | |
| 194.13% | $218.01M | |
| -596.44% | $445.68M | |
| -38.70% | $214.14M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Eupraxia Pharmaceuticals Inc.'s ROE?
How is the ROE calculated for Eupraxia Pharmaceuticals Inc. (EPRX)?
What is the highest ROE for Eupraxia Pharmaceuticals Inc. (EPRX)?
What is the 3-year average ROE for Eupraxia Pharmaceuticals Inc. (EPRX)?
What is the 5-year average ROE for Eupraxia Pharmaceuticals Inc. (EPRX)?
How does the current ROE for Eupraxia Pharmaceuticals Inc. (EPRX) compare to its historical average?